Cashu | Summary | KURA

HomeWatchlistNewsSignalsPicks

DJI

+1.05%

SPX

+1.03%

IXIC

+1.20%

FTSE

+0.30%

N225

+0.50%

AXJO

-0.27%

HomeWatchlistNewsSignalsPicks

Stocks

0.00 (0.00%)

0.000

USD

At close at --,----

Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

About Us
Careers
Blog
News

Help & Support

Help Center
Contact Us
Pro Support

Legal

Privacy Policy
Terms of Use

Instagram YouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...

Join our newsletter to keep up to date with us!

Key Stats

Market Cap

530.56M

Dividend Yield

0.00%

P/E Ratio

-2.92

EPS

-2.03

Revenue

53.88M

Avg. Volume

1.13M

Recently from Cashu

Kura Oncology Partners with Peanuts for Exciting Limited-Time Sushi Promotion

about 1 month ago

Kura Oncology Partners with Peanuts for Unique Dining Promotion at Kura Sushi

about 1 month ago

About

What does KURA do?

Kura Oncology, headquartered in San Diego, focuses on developing precision medicines for cancer treatment, including small molecule candidates Ziftomenib, Tipifarnib, and KO-2806. The company went public in November 2015 and employs 142 staff.

Sector

💻 Health Care

IPO

CEO

Employees

Headquarters

California, USA

Website

http://www.kuraoncology.com

Stocks

Health Care

kura

Kura Oncology

KURA

+0.16 (+2.44%)

6.73

USD

At close at Jun 06, 20:41 UTC